Surface chemistry of carbon nanoparticles functionally select their uptake in various stages of cancer cells
Surface chemistry of carbon nanoparticles functionally select their uptake in various stages of cancer cells作者机构：Department of Bioengineering University of Illinois Urbana-Champaign Urbana Illinois 61801 USA Biomedical Research Center Carle Foundation Hospital Urbana Illinois 61801 USA Department of Materials Science and Beckman Institute University of illinois Urbana-Champaign Urbana Illinois 61801 USA
出 版 物：《Nano Research》 (纳米研究（英文版）)
年 卷 期：2017年第10卷第10期
页 面：3269-3284页
核心收录：
学科分类：080503[工学-材料加工工程] 0808[工学-电气工程] 1002[医学-临床医学] 0809[工学-电子科学与技术（可授工学、理学学位）] 08[工学] 0805[工学-材料科学与工程（可授工学、理学学位）] 100214[医学-肿瘤学] 0702[理学-物理学] 10[医学]
基 金：University of Illinois at Urbana-Champaign, UIUC Children's Discovery Institute, CDI
主 题：personalized medicine endocytosis surface charge size carbon nanoparticles
摘 要：Relationship of the surface physicochemical characteristics of nanoparticles with their interactions with biological entities may provide critical information for nanomedicinal application. Here, we report the systematic synthesis of sub-50 nm carbon nanoparticles （CNP） presenting neutral, anionic, and cationic surface functionalities. A subset of CNPs with -10, 20, and 40 nm hydrodynamic sizes were synthesized with neutral surface headgroups. For the first time, the cellular internalization of these CNPs was systematically quantified in various stages of breast cancer cells （early, late, and metastatic）, thereby providing a parametric assessment of charge and size effects. Distinct activities were observed when these systems interacted with cancer cells in various stages. Our results indicated that metastatic breast cancer could be targeted by a nanosystem presenting anionic phosphate groups. On the contrary, for patients in late stage of cancer, drugs could be delivered with sulfonate functionalized carbon nano- particles, which have higher probability of intracellular transport. This study will facilitate the better understanding of nanoparticle-biological entity interaction, and the integration of this knowledge with pathophysiology would promote the engineering of nanomedicine with superior likelihoods of crossing the endocytic ＂barrier＂ for drug delivery inside cancerous cells.
维普期刊数据库